2017
DOI: 10.1016/j.canlet.2017.08.021
|View full text |Cite
|
Sign up to set email alerts
|

Up-regulation of OLR1 expression by TBC1D3 through activation of TNFα/NF-κB pathway promotes the migration of human breast cancer cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
27
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 41 publications
(29 citation statements)
references
References 54 publications
2
27
0
Order By: Relevance
“…To enable the thorough exploration of LINC00467 in the molecular regulation of HCC, the UCSC database was utilized and then the gene for TRAF5 was discovered to be a neighboring gene of that for LINC00467. As a result of the significant role of TRAF5 in the progression of different cancers, such as colorectal cancer, prostate cancer and breast cancer, TRAF5 was selected to be studied. In the present study, the expression of TRAF5 was positively modulated by LINC00467 in HCC.…”
Section: Discussionmentioning
confidence: 99%
“…To enable the thorough exploration of LINC00467 in the molecular regulation of HCC, the UCSC database was utilized and then the gene for TRAF5 was discovered to be a neighboring gene of that for LINC00467. As a result of the significant role of TRAF5 in the progression of different cancers, such as colorectal cancer, prostate cancer and breast cancer, TRAF5 was selected to be studied. In the present study, the expression of TRAF5 was positively modulated by LINC00467 in HCC.…”
Section: Discussionmentioning
confidence: 99%
“…Based on online literature search, we found that OLR1, GPNMB, PRRX1 and BCAT1 promote cancer migration and invasion in various types of cancer. Specifically, OLR1 has been recognized as a cell migration stimulator in breast cancer cells, and potentially up‐regulated by oncogene TBC1D3 through activation of TNFa/NF‐ K B pathway . Non‐metastatic glycoprotein melanoma protein B (GPNMB), also known as osteoactivin (OA) is expressed in verified tumours and represents an emerging target for drug development.…”
Section: Discussionmentioning
confidence: 99%
“…Their results showed that this factor was highly expressed in MDA-MB-231 cells; furthermore, a downregulation of CD74 inhibited both migration and invasion of MDA-MB-231 cells. Wang et al [ 88 ] reported that TBC1D3 oncogene promotes the migration of breast cancer cells, and its interaction with calmodulin enhances the effects of TBC1D3.…”
Section: Discussionmentioning
confidence: 99%